In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Novimmune SA

www.novimmune.com

Latest From Novimmune SA

Moment Of Truth For Belantamab Mafodotin, Trikafta And Turalio At EMA

A number of drug companies are set to learn the fate of their marketing authorization applications in the EU this week.

Drug Review Europe

Isatuximab EU Approval Decision Due

Recommending new medicines for approval and allowing sponsors of others extra time to answer outstanding questions are among the many tasks on the agenda of the March meeting of European Medicines Agency's key scientific committee, the CHMP. The meeting has been taking place, remotely, this week.

Europe Drug Review

Sobi Reaps Benefits From Acquisitions, Commercial Focus

Sweden’s mid-sized pharmaceutical company, Swedish Orphan Biovitrum, has expanded into hematology and strengthened its immunology business, growing its top and bottom lines in 2019.

Sales & Earnings Deals

Sobi Targets Thrombocytopenia In $915m Swoop For Dova

The Swedish group has got hold of the ITP and CLD drug Doptelet, widening its hematology business beyond hemophilia.

M & A Blood & Coagulation Disorders
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
      • Antibodies
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Immune Disorders
  • Inflammation
  • Alias(es)
  • NovImmune SA
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Switzerland
  • Parent & Subsidiaries
  • Novimmune SA
  • Senior Management
  • Erik Trock-Jansen, CEO
    Sven Zimmermann, CFO
    Adrian Mills, CBO
    Cristina de Min , MD, CMO
  • Contact Info
  • Novimmune SA
    Phone: (41) 22 839 71 41
    14 Chemin des Aulx
    Plan-Les-Ouates
    Geneva, 1228
    Switzerland
UsernamePublicRestriction

Register